248 related articles for article (PubMed ID: 28236427)
1. Procoagulant extracellular vesicles in amniotic fluid.
Hell L; Wisgrill L; Ay C; Spittler A; Schwameis M; Jilma B; Pabinger I; Altevogt P; Thaler J
Transl Res; 2017 Jun; 184():12-20.e1. PubMed ID: 28236427
[TBL] [Abstract][Full Text] [Related]
2. Procoagulant activity and phosphatidylserine of amniotic fluid cells.
Zhou J; Liu S; Ma M; Hou J; Yu H; Lu C; Gilbert GE; Shi J
Thromb Haemost; 2009 May; 101(5):845-51. PubMed ID: 19404537
[TBL] [Abstract][Full Text] [Related]
3. Procoagulant Activity in Amniotic Fluid Is Associated with Fetal-Derived Extracellular Vesicles.
Butov KR; Karetnikova NA; Pershin DY; Trofimov DY; Panteleev MA
Curr Issues Mol Biol; 2022 Jun; 44(6):2710-2716. PubMed ID: 35735626
[TBL] [Abstract][Full Text] [Related]
4. Coagulation and fibrinolysis in amniotic fluid: physiology and observations on amniotic fluid embolism, preterm fetal membrane rupture, and pre-eclampsia.
Uszyński M; Uszyński W
Semin Thromb Hemost; 2011 Mar; 37(2):165-74. PubMed ID: 21370219
[TBL] [Abstract][Full Text] [Related]
5. Vincristine induces procoagulant activity of the human lymphoblastic leukemia cell line Jurkat through the release of extracellular vesicles.
Pluchart C; Poitevin G; Colinart-Thomas M; Guimard G; Audonnet S; Terryn C; Nguyen P
J Thromb Thrombolysis; 2019 Aug; 48(2):195-202. PubMed ID: 31175530
[TBL] [Abstract][Full Text] [Related]
6. Procoagulant activity of extracellular vesicles as a potential biomarker for risk of thrombosis and DIC in patients with acute leukaemia.
Gheldof D; Haguet H; Dogné JM; Bouvy C; Graux C; George F; Sonet A; Chatelain C; Chatelain B; Mullier F
J Thromb Thrombolysis; 2017 Feb; 43(2):224-232. PubMed ID: 28074413
[TBL] [Abstract][Full Text] [Related]
7. Amniotic fluid embolism: the complication of known pathomechanism but without pathogenetic therapy?
Uszynski M
Thromb Haemost; 2009 May; 101(5):795-6. PubMed ID: 19404526
[No Abstract] [Full Text] [Related]
8. Extracellular vesicle-associated procoagulant activity is highest the first 3 hours after trauma and thereafter declines substantially: A prospective observational pilot study.
Rognes IN; Hellum M; Ottestad W; Bache KG; Eken T; Henriksson CE
J Trauma Acute Care Surg; 2021 Oct; 91(4):681-691. PubMed ID: 34225342
[TBL] [Abstract][Full Text] [Related]
9. Breast-cancer extracellular vesicles induce platelet activation and aggregation by tissue factor-independent and -dependent mechanisms.
Gomes FG; Sandim V; Almeida VH; Rondon AMR; Succar BB; Hottz ED; Leal AC; Verçoza BRF; Rodrigues JCF; Bozza PT; Zingali RB; Monteiro RQ
Thromb Res; 2017 Nov; 159():24-32. PubMed ID: 28950217
[TBL] [Abstract][Full Text] [Related]
10. Different Potential of Extracellular Vesicles to Support Thrombin Generation: Contributions of Phosphatidylserine, Tissue Factor, and Cellular Origin.
Tripisciano C; Weiss R; Eichhorn T; Spittler A; Heuser T; Fischer MB; Weber V
Sci Rep; 2017 Jul; 7(1):6522. PubMed ID: 28747771
[TBL] [Abstract][Full Text] [Related]
11. Cancer Cell-Derived Extracellular Vesicles Are Associated with Coagulopathy Causing Ischemic Stroke via Tissue Factor-Independent Way: The OASIS-CANCER Study.
Bang OY; Chung JW; Lee MJ; Kim SJ; Cho YH; Kim GM; Chung CS; Lee KH; Ahn MJ; Moon GJ
PLoS One; 2016; 11(7):e0159170. PubMed ID: 27427978
[TBL] [Abstract][Full Text] [Related]
12. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death.
Erez O; Gotsch F; Mazaki-Tovi S; Vaisbuch E; Kusanovic JP; Kim CJ; Chaiworapongsa T; Hoppensteadt D; Fareed J; Than NG; Nhan-Chang CL; Yeo L; Pacora P; Mazor M; Hassan SS; Mittal P; Romero R
J Matern Fetal Neonatal Med; 2009 Aug; 22(8):672-87. PubMed ID: 19736615
[TBL] [Abstract][Full Text] [Related]
13. The tissue factor pathway in disseminated intravascular coagulation.
Østerud B; Bjørklid E
Semin Thromb Hemost; 2001 Dec; 27(6):605-17. PubMed ID: 11740684
[TBL] [Abstract][Full Text] [Related]
14. The procoagulant activity of tissue factor expressed on fibroblasts is increased by tissue factor-negative extracellular vesicles.
Rosas M; Slatter DA; Obaji SG; Webber JP; Alvarez-Jarreta J; Thomas CP; Aldrovandi M; Tyrrell VJ; Jenkins PV; O'Donnell VB; Collins PW
PLoS One; 2020; 15(10):e0240189. PubMed ID: 33031441
[TBL] [Abstract][Full Text] [Related]
15. Extracellular vesicles from amniotic fluid, milk, saliva, and urine expose complexes of tissue factor and activated factor VII.
Hu Y; Repa A; Lisman T; Yerlikaya-Schatten G; Hau C; Pabinger I; Ay C; Nieuwland R; Thaler J
J Thromb Haemost; 2022 Oct; 20(10):2306-2312. PubMed ID: 35748324
[TBL] [Abstract][Full Text] [Related]
16. Effects of platelets activated by different agonists on fibrin formation and thrombin generation.
Muravlev IA; Dobrovolsky AB; Antonova OA; Khaspekova SG; Mazurov AV
Platelets; 2023 Dec; 34(1):2139365. PubMed ID: 36325627
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients.
Zhao L; Bi Y; Kou J; Shi J; Piao D
J Exp Clin Cancer Res; 2016 Mar; 35():54. PubMed ID: 27015840
[TBL] [Abstract][Full Text] [Related]
18. New observations on procoagulant properties of amniotic fluid: microparticles (MPs) and tissue factor-bearing MPs (MPs-TF), comparison with maternal blood plasma.
Uszyński W; Zekanowska E; Uszyński M; Zyliński A; Kuczyński J
Thromb Res; 2013; 132(6):757-60. PubMed ID: 24157083
[TBL] [Abstract][Full Text] [Related]
19. Increased blood cell phosphatidylserine exposure and circulating microparticles contribute to procoagulant activity after carotid artery stenting.
Zhao L; Wu X; Si Y; Yao Z; Dong Z; Novakovic VA; Guo L; Tong D; Chen H; Bi Y; Kou J; Shi H; Tian Y; Hu S; Zhou J; Shi J
J Neurosurg; 2017 Nov; 127(5):1041-1054. PubMed ID: 28009236
[TBL] [Abstract][Full Text] [Related]
20. The procoagulant effects of extracellular vesicles derived from hypoxic endothelial cells can be selectively inhibited by inorganic nitrite.
Whelan C; Burnley-Hall N; Morris K; Rees DA; James PE
Nitric Oxide; 2022 May; 122-123():6-18. PubMed ID: 35202833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
